Cite

HARVARD Citation

    Xiao, Y. et al. (2023). The cost‐effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030. Medical journal of Australia. 218 (4), pp. 168-173. [Online]. 
  
Back to record